{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.45","value":"-0.30"},{"groupId":"OG001","spread":"0.59","value":"-0.52"},{"groupId":"OG002","spread":"0.60","value":"-0.52"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"229"},{"groupId":"OG002","value":"227"}],"units":"Participants"}],"description":"The HAQ-DI questionnaire assesses the participant's self-perception on the degree of difficulty (0 \\[without any difficulty\\], 1 \\[with some difficulty\\], 2 \\[with much difficulty\\], and 3 \\[unable to do\\])when dressing and grooming, arising, eating, walking, hygiene, reaching, gripping, and performing other daily activities. Scores for each functional area were averaged to calculate the HAQ-DI score, which ranged from 0 (no disability) to 3 (worst disability). A decrease in HAQ-DI score indicated an improvement in the participant's condition.","dispersionType":"Standard Deviation","groups":[{"description":"Placebo administered orally once daily through Week 24.\n\nParticipants continued to take background conventional disease-modifying antirheumatic drug (cDMARD) therapy throughout study.","id":"OG000","title":"Placebo"},{"description":"Baricitinib 2 mg administered orally once daily through Week 24.\n\nParticipants continued to take background cDMARD therapy throughout study.","id":"OG001","title":"Baricitinib 2 mg"},{"description":"Baricitinib 4 mg administered orally once daily through Week 24.\n\nParticipants continued to take background cDMARD therapy throughout study.","id":"OG002","title":"Baricitinib 4 mg"}],"paramType":"MEAN","populationDescription":"mITT population: all randomized participants who received at least 1 dose of the study drug. Missing values due to discontinuation of study or drug, rescue, or missing data were imputed using modified baseline observation carried forward (mBOCF).","reportingStatus":"POSTED","timeFrame":"Baseline, Week 12","title":"Change From Baseline in the Health Assessment Questionnaire-Disability Index (HAQ-DI) Score","type":"SECONDARY","unitOfMeasure":"units on a scale"}